OBJECTIVE: To assess the potential benefit of preimplantation aneuploidy testing on the outcome of in vitro fertilization (IVF) for women of advanced maternal age (AMA). DESIGN: Prospective randomized clinical trial. SETTING: Private IVF clinic. PATIENT(S): Sixty-two infertile AMA couples undergoing fertility treatment. INTERVENTION(S): Fluorescent in situ hybridization (FISH) for chromosomes X, Y, 13, 15, 16, 17, 18, 21, and 22. MAIN OUTCOME MEASURE(S): Preimplantation aneuploidy testing of biopsied blastomeres on day 3 of development. RESULT(S): Fertilization and blastocyst developmental rates were similar for the test and control groups: 80% versus 77.4% and 49% versus 48.2%, respectively. The average number of embryos transferred was comparable at 2.2 for the test group and 2.7 for the control group. Implantation rates were also equivalent across the two groups: 37.3% in the control group versus 36.5% in the test group. Nevertheless, the spontaneous abortion rate was observed to be lower for the test group: 25.9% versus 32.26% in the control group. This resulted in an observed increase in delivery rates for the test group: 78% versus 67.74% in the control group. CONCLUSION(S): Preimplantation aneuploidy testing does not appear to statistically significantly improve outcome parameters in infertile AMA patients; however, a trend toward a decrease in the spontaneous abortion rate with a subsequent higher delivery rate was observed.
RCT Entities:
OBJECTIVE: To assess the potential benefit of preimplantation aneuploidy testing on the outcome of in vitro fertilization (IVF) for women of advanced maternal age (AMA). DESIGN: Prospective randomized clinical trial. SETTING: Private IVF clinic. PATIENT(S): Sixty-two infertile AMA couples undergoing fertility treatment. INTERVENTION(S): Fluorescent in situ hybridization (FISH) for chromosomes X, Y, 13, 15, 16, 17, 18, 21, and 22. MAIN OUTCOME MEASURE(S): Preimplantation aneuploidy testing of biopsied blastomeres on day 3 of development. RESULT(S): Fertilization and blastocyst developmental rates were similar for the test and control groups: 80% versus 77.4% and 49% versus 48.2%, respectively. The average number of embryos transferred was comparable at 2.2 for the test group and 2.7 for the control group. Implantation rates were also equivalent across the two groups: 37.3% in the control group versus 36.5% in the test group. Nevertheless, the spontaneous abortion rate was observed to be lower for the test group: 25.9% versus 32.26% in the control group. This resulted in an observed increase in delivery rates for the test group: 78% versus 67.74% in the control group. CONCLUSION(S): Preimplantation aneuploidy testing does not appear to statistically significantly improve outcome parameters in infertile AMApatients; however, a trend toward a decrease in the spontaneous abortion rate with a subsequent higher delivery rate was observed.
Authors: Kirstine Kirkegaard; Johnny Juhl Hindkjaer; Marie Louise Grøndahl; Ulrik Schiøler Kesmodel; Hans Jakob Ingerslev Journal: J Assist Reprod Genet Date: 2012-03-30 Impact factor: 3.412
Authors: D Ioannou; K G L Fonseka; E J Meershoek; A R Thornhill; A Abogrein; M Ellis; D K Griffin Journal: Chromosome Res Date: 2012-06-29 Impact factor: 5.239
Authors: Martin D Keltz; Mario Vega; Ido Sirota; Matthew Lederman; Erin L Moshier; Eric Gonzales; Daniel Stein Journal: J Assist Reprod Genet Date: 2013-08-16 Impact factor: 3.412
Authors: Miguel A Checa; Pablo Alonso-Coello; Ivan Solà; Ana Robles; Ramón Carreras; Juan Balasch Journal: J Assist Reprod Genet Date: 2009-07-24 Impact factor: 3.412
Authors: Sandra Zamora; Ana Clavero; M Carmen Gonzalvo; Juan de Dios Luna Del Castillo; Jose Antonio Roldán-Nofuentes; Juan Mozas; Jose Antonio Castilla Journal: J Assist Reprod Genet Date: 2011-06-29 Impact factor: 3.412
Authors: Alessia Nicoli; Francesco Capodanno; Lucia Moscato; Ilaria Rondini; Maria T Villani; Antonella Tuzio; Giovanni B La Sala Journal: Reprod Biol Endocrinol Date: 2010-06-25 Impact factor: 5.211